PURPOSE OF REVIEW: Anaplastic thyroid cancer (ATC) is a rare and deadly malignancy. There is a need to speed up and support clinical research. This review article focuses on the new molecules that have been developed for the treatment of this aggressive tumor. RECENT FINDINGS: Improvement in the knowledge of pathogenesis and genetics of ATC led to the development of a variety of new molecules that may be used to treat this disease. In summary, these molecules are proteasome inhibitors, Aurora kinase inhibitors, vascular targeting agents, and gene therapies. All these molecules demonstrated a potentially therapeutic activity in metastatic ATC. To date, the largest prospective randomized multicenter, open-label, trial was conducted with combretastatin-A4. SUMMARY: More efficient drugs need to be developed through multinational efforts.
PURPOSE OF REVIEW: Anaplastic thyroid cancer (ATC) is a rare and deadly malignancy. There is a need to speed up and support clinical research. This review article focuses on the new molecules that have been developed for the treatment of this aggressive tumor. RECENT FINDINGS: Improvement in the knowledge of pathogenesis and genetics of ATC led to the development of a variety of new molecules that may be used to treat this disease. In summary, these molecules are proteasome inhibitors, Aurora kinase inhibitors, vascular targeting agents, and gene therapies. All these molecules demonstrated a potentially therapeutic activity in metastatic ATC. To date, the largest prospective randomized multicenter, open-label, trial was conducted with combretastatin-A4. SUMMARY: More efficient drugs need to be developed through multinational efforts.
Authors: Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen Journal: Oncologist Date: 2014-09-26
Authors: Sabine Wächter; C Vorländer; J Schabram; I Mintziras; I Fülber; J Manoharan; K Holzer; D K Bartsch; E Maurer Journal: Eur Arch Otorhinolaryngol Date: 2020-02-14 Impact factor: 2.503
Authors: Amit Mehta; Lisa Zhang; Myriem Boufraqech; Yi Liu-Chittenden; Yaqin Zhang; Dhaval Patel; Sean Davis; Avi Rosenberg; Kris Ylaya; Rachel Aufforth; Zhuyin Li; Min Shen; Electron Kebebew Journal: Clin Cancer Res Date: 2015-05-05 Impact factor: 13.801
Authors: Marjan Talebi; Mohsen Talebi; Tahereh Farkhondeh; Jesus Simal-Gandara; Dalia M Kopustinskiene; Jurga Bernatoniene; Saeed Samarghandian Journal: Cancer Cell Int Date: 2021-04-15 Impact factor: 5.722
Authors: S Eckhardt; S Hoffmann; A I Damanakis; P Di Fazio; A Pfestroff; M Luster; A Wunderlich; D K Bartsch Journal: Int J Surg Case Rep Date: 2016-06-16